LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported a loss of $3.8 million in its first quarter.
The Los Angeles-based company said it had a loss of 7 cents per share. Losses, adjusted for stock option expense, came to 4 cents per share.
The biopharmaceutical company posted revenue of $44.8 million in the period.
For the current quarter ending in June, Puma Biotech said it expects revenue in the range of $52 million to $55 million.
The company expects full-year revenue in the range of $222 million to $229 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/PBYI
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.